Back
Moleculin Biotech, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
MBRX
Moleculin Biotech, Inc.
Last Price:
$3.87
Seasonality Move:
-20.11%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBRX is experiencing slight selling pressure.
Moleculin Biotech, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.1 | Sell |
| 20-day SMA: | 5.56 | Sell |
| 50-day SMA: | 9.18 | Sell |
| 200-day SMA: | 15.5 | Sell |
| 8-day EMA: | 4.27 | Sell |
| 20-day EMA: | 5.68 | Sell |
| 50-day EMA: | 8.16 | Sell |
| 200-day EMA: | 20.66 | Sell |
Moleculin Biotech, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.6 | Sell |
| Relative Strength Index (14 RSI): | 24.58 | Sell |
| Chaikin Money Flow: | -36984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.22 - 8.7) | Sell |
| Bollinger Bands (100): | (7.48 - 14.16) | Sell |
Moleculin Biotech, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Moleculin Biotech, Inc. Stock
Is Moleculin Biotech, Inc. Stock a Buy?
-
Moleculin Biotech, Inc. share price is 3.83 while MBRX 8-day simple moving average is 4.10, which is a Sell signal.
-
The stock price of MBRX is 3.83 while Moleculin Biotech, Inc. 20-day SMA is 5.56, which makes it a Sell.
-
Moleculin Biotech, Inc. 50-day simple moving average is 9.18 while MBRX share price is 3.83, making it a Sell technically.
-
MBRX stock price is 3.83 and Moleculin Biotech, Inc. 200-day simple moving average is 15.50, creating a Sell signal.
MBRX Technical Analysis vs Fundamental Analysis
Sell
11
Moleculin Biotech, Inc. (MBRX)
is a Sell
Is Moleculin Biotech, Inc. a Buy or a Sell?
-
Moleculin Biotech, Inc. stock is rated a SellThe current Moleculin Biotech, Inc. [MBRX] share price is $3.83. The Score for MBRX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Moleculin Biotech, Inc. Stock Info
Market Cap:
7.9M
Price in USD:
3.83
Share Volume:
90.7K
Moleculin Biotech, Inc. 52-Week Range
52-Week High:
91.25
52-Week Low:
3.63
Sell
11
Moleculin Biotech, Inc. (MBRX)
is a Sell
Moleculin Biotech, Inc. Share Price Forecast
-
What is the Moleculin Biotech, Inc. stock price today?The Moleculin Biotech, Inc. stock price is 3.83 USD today.
-
Will MBRX stock go up or go down?Moleculin Biotech, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Moleculin Biotech, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Moleculin Biotech, Inc. is overvalued.
Is Moleculin Biotech, Inc. Stock a Buy?
-
Moleculin Biotech, Inc. share price is 3.83 while MBRX 8-day exponential moving average is 4.27, which is a Sell signal.
-
The stock price of MBRX is 3.83 while Moleculin Biotech, Inc. 20-day EMA is 5.68, which makes it a Sell.
-
Moleculin Biotech, Inc. 50-day exponential moving average is 8.16 while MBRX share price is 3.83, making it a Sell technically.
-
MBRX stock price is 3.83 and Moleculin Biotech, Inc. 200-day simple moving average is 20.66, creating a Sell signal.
Fundamental Analysis of Moleculin Biotech, Inc.
Is Moleculin Biotech, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $220.25 per share, and an increase next year of $10.75 per share.
Technical Analysis of Moleculin Biotech, Inc.
Should I short Moleculin Biotech, Inc. stock?
-
MBRX Moving Average Covergence Divergence (MACD) indicator is -1.6, suggesting Moleculin Biotech, Inc. is a Sell
-
Moleculin Biotech, Inc. Relative Strength Index (RSI) is 24.58, which suggest Moleculin Biotech, Inc. is oversold
-
The Bollinger Bands (25) for Moleculin Biotech, Inc. is (4.22 - 8.7), which suggest Moleculin Biotech, Inc. is a Sell
-
The Bollinger Bands (100) for Moleculin Biotech, Inc. is (7.48 - 14.16), which suggest Moleculin Biotech, Inc. is a Sell
* Moleculin Biotech, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.